Skip to content

A randomized controlled trial for 'tonifying kidney and removing blood stasis' traditional Chinese medicine in the treatment of patients with decreased ovarian reserve after chocolate cyst removal

A randomized controlled trial for 'tonifying kidney and removing blood stasis' traditional Chinese medicine in the treatment of patients with decreased ovarian reserve after chocolate cyst removal

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023602
Enrollment
Unknown
Registered
2019-06-03
Start date
2019-06-03
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian dysfunction

Interventions

Sponsors

Department of gynecology, Fangcun Branch of Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 39 Years

Inclusion criteria

Inclusion criteria: (1) aged 18-39 years; (2) iatrogenic ovarian reserve function decreased after the operation of ovarian endometriosis (removal of cysts, unilateral adnexectomy, and intervention); (3) decreased ovarian reserve function: AMH was lower than the lower limit of the reference range of this age group (referring to the AMH test of patients, the standard of our hospital was: 20-24 years old: 1.52ng/ml, 25-29 years old: 1.2ng/ml, 30-34 years old: 0.711ng/ml, 36-39 years old: 0.405ng/ml);The follicular count of basal sinus was less than 5 at the 2nd to 5th day of menstruation. The basic FSH value on the 2-5 days of menstruation was greater than 10IU/L. The basic E2 value on the 2-5 days of menstruation was greater than 80pg/ml. Any one of the above four indicators can be included; (4) normal menstruation before operation.Show menstruation is normal or abnormal, but menstruation closes time 3 months less than; (5) TCM syndrome differentiation belongs to kidney deficiency and blood stasis; (6) informed consent.

Exclusion criteria

Exclusion criteria: (1) use hormones at present or within 3 months before enrollment; (2) irregular menstruation before operation. Menstrual arrested over 3 months; (3) congenital gonadal hypoplasia; With a history of autoimmune diseases, pelvic infectious diseases, mumps, etc.; (4) polycystic ovary syndrome, hyperprolactinemia, dysfunctional uterine bleeding, hypogonadotropin, hypothyroidism and other endocrine diseases (disorders); (5) surgery history for other adnexas; (6) With a history of using reproductive toxic drugs, chemotherapy drugs and radiotherapy; (7) suspected genetic factors of ovarian decline; (8) pregnant or lactating women; (9) people with bad living habits (such as frequent smoking, excessive drinking, frequent hair coloring, excessive weight loss, etc.); (10) patients with severe mental illness; (11) participated in other clinical trials in the past 3 months; (12) bilateral adnexectomy due to Chocolate cyst; Chocolate cyst recurrence.

Design outcomes

Primary

MeasureTime frame
Anti mullerian canal hor;Ovulation;menstrual cycle;Assessment of menstrual volume;

Secondary

MeasureTime frame
rate of pregnancy;Endometriosis quality of life scale (ehp-5);Follicle-Stimulating Hormone;Luteinizing Hormone;oestrogen;Sinus follicular count;

Countries

China

Contacts

Public ContactWang Yongxia

Department of gynecology, Guangdong Provincial Hospital of Traditional Chinese Medicine

454616332@qq.com+86 13631465867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026